FDA
approval
· 2016-12-16
FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
Summary
The FDA approved a supplemental application for nalbuphine hydrochloride from Hospira, Inc., authorizing a change to the product’s approval.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE)